Sep 22, 2011
Cambridge Healthtech Institute (CHI) is pleased to offer this pre-conference short course on Tuesday, November 15 at the DoubleTree Hotel in Bethesda, MD.
Sep 19, 2011
Cambridge Healthtech Institute (CHI) is pleased to offer this pre-conference short course on Tuesday, November 15 at the DoubleTree Hotel in Bethesda, MD.
Sep 01, 2011
To better meet the needs of the pharmaceutical industry, CHI just added a special session at its third annual Accelerating Proof-of-Concept conference, to be held on October 3-5, 2011 at the Crowne Plaza Hotel Downtown in Philadelphia, PA.
Aug 31, 2011
Delegates now have the option to choose from 9 moderated breakout discussion groups at this conference that is set for October 3-4, 2011, Cambridge, MA (part of CHI's Barnett Clinical Summit: Optimizing Trial Management).
Aug 30, 2011
Delegates now have the option to choose from 10 moderated breakout discussion groups at this conference that is set for October 3-4, 2011, Cambridge, MA (part of CHI's Barnett Clinical Summit: Optimizing Trial Management).
Aug 25, 2011
Cambridge Healthtech Institute announces three sponsors and presenters at upcoming conference set for November 3-5, 2011 in Philadelphia: Biovista, Cetero Research, and Lotus Clinical Research, LLC.
Aug 25, 2011
3 hour course to be held in Boston on November 17 lead by David Kaplan, Ph.D., Tufts University; Melik Demirel, Ph.D., Pennsylvania University; Derek J. Hansford, Ph.D., Ohio State University; and Umut A. Gurkan, Ph.D., Harvard-MIT.
Aug 24, 2011
Early registration discounts (up to $400 off a conference registration) will be offered until August 26.
Aug 11, 2011
Two thought-leaders and experts on phase II clinical trials will be the keynote speakers at the CHI’s Accelerating Proof of Concept: Clinical Success Driven by Science & Strategy, set for October 3-5 at the Crowne Plaza Hotel in Philadelphia, PA.
Aug 05, 2011
This summit (part of CHI's Third Annual Immunogenicity Summit) is scheduled for November 17-18, 2011 at the DoubleTree Hotel in Bethesda, MD.